Different distribution of plexiform lesions in primary and secondary pulmonary hypertension.
暂无分享,去创建一个
[1] G. Simonneau,et al. Primary pulmonary hypertension and fenfluramine use. , 1993, British heart journal.
[2] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[3] L V McIntire,et al. Cyclical strain effects on production of vasoactive materials in cultured endothelial cells , 1992, Journal of cellular physiology.
[4] B. Shuckett,et al. Association of pulmonary hypertension with congenital portal hypertension in a child. , 1992, The Journal of pediatrics.
[5] W. K. Adkins,et al. Sustained effects of endothelin-1 on rabbit, dog, and rat pulmonary circulations. , 1991, The American journal of physiology.
[6] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[7] D. Moodie,et al. Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. , 1991, Journal of the American College of Cardiology.
[8] P. Braquet,et al. Pulmonary vascular response to endothelin in rats. , 1991, Journal of applied physiology.
[9] H. Mohri,et al. Distribution of arterial lesions and collateral pathways in the pulmonary hypertension of congenital heart disease: a computer aided reconstruction study. , 1990, Thorax.
[10] B. Madden,et al. The ultrastructure of plexogenic pulmonary arteriopathy , 1990, The Journal of pathology.
[11] J. Clozel,et al. Effects of endothelin on regional blood flows in squirrel monkeys. , 1989, The Journal of pharmacology and experimental therapeutics.
[12] M. Yanagisawa,et al. A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts. , 1989, The Journal of biological chemistry.
[13] T. Hauth,et al. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. , 1989, Journal of applied physiology.
[14] Sadao Kimura,et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.
[15] W. Edwards,et al. Coexistent pulmonary and portal hypertension: morphologic and clinical features. , 1987, Journal of the American College of Cardiology.
[16] C. Wagenvoort,et al. Comparison of primary plexogenic arteriopathy in adults and children. A morphometric study in 40 patients. , 1985, British heart journal.
[17] V. Fuster,et al. Primary pulmonary hypertension: natural history and the importance of thrombosis. , 1984, Circulation.
[18] C. Bloor,et al. The Pulmonary and Bronchial Circulations in Congenital Heart Disease , 1980, Topics in Cardiovascular Disease.
[19] D. Dhumeaux,et al. Pulmonary hypertension complicating portal hypertension. , 1979, The American review of respiratory disease.
[20] D. Heath,et al. Electron microscopy of the plexiform lesion. , 1979, Thorax.
[21] A. Fishman. Dietary Pulmonary Hypertension , 1974, Circulation research.
[22] C. Wagenvoort,et al. Primary Pulmonary Hypertension: A Pathologic Study of the Lung Vessels in 156 Clinically Diagnosed Cases , 1970 .
[23] C. Ferencz,et al. A method for the three-dimensional study of pulmonary arteries. , 1970, Chest.
[24] C. Carrington,et al. Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. , 1968, The American journal of pathology.
[25] N. Cauna. Stammesgeschichte der Säugetiere. Eine Übersicht über Tatsachen und Probleme der Evolution der Säugetiere , 1962 .
[26] J. Edwards,et al. The Pathology of Hypertensive Pulmonary Vascular Disease: A Description of Six Grades of Structural Changes in the Pulmonary Arteries with Special Reference to Congenital Cardiac Septal Defects , 1958, Circulation.
[27] W. Brinton. PRIMARY PULMONARY HYPERTENSION , 1950, British heart journal.
[28] J. Fung,et al. Reversibility of pulmonary hypertension after liver transplantation : a case report , 1993 .
[29] T. Iijima,et al. Structure and pathogenesis of plexiform lesion in pulmonary hypertension. , 1993, Chinese medical journal.
[30] I. Cameron,et al. A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. , 1992, Clinical science.
[31] M. Yacoub,et al. Plexiform lesion in bronchopulmonary anastomosis. , 1988, British journal of diseases of the chest.
[32] D. Heath,et al. Electron microscopy of hypertensive pulmonary vascular disease. , 1983, British journal of diseases of the chest.
[33] Meyrick Bo,et al. Crotalaria-induced pulmonary hypertension. Uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. , 1982 .
[34] C. Wagenvoort,et al. Pathology of pulmonary hypertension , 1977 .
[35] D. Heath,et al. The Human Pulmonary Circulation: Its Form and Function in Health and Disease , 1977 .
[36] S. Widgren. Pulmonary hypertension related to aminorex intake. Histologic, ultrastructural, and morphometric studies of 37 cases in Switzerland. , 1977, Current topics in pathology. Ergebnisse der Pathologie.
[37] K. Benirschke,et al. Current Topics in Pathology , 1974, Current Topics in Pathology.
[38] D. Heath,et al. Pulmonary vascular changes in Eisenmenger's complex. , 1959, The Journal of pathology and bacteriology.
[39] H. Spencer. Primary pulmonary hypertension and related vascular changes in the lungs. , 1950, The Journal of pathology and bacteriology.
[40] G. F. Petrie. The occurrence of typhoidal bacilluria in a horse , 1936 .